Today’s news
Ketone Boost Enhances Immunotherapy, Human Trials Begin
A naturally occurring metabolite can strengthen CAR T cells to improve tumor control across multiple cancer models.

Mira Costa High Students Host Blood Cancer United Fundraiser
Art exhibition and community event to support blood cancer research and patient care
Scientists Crack Ovarian Cancer's Immunotherapy Code
Researchers find way to boost immune system's ability to recognize and attack ovarian tumors.
Recent news
Mar. 5, 2026
UCLA Team Engineers CAR-T Cells to Fight Tough Tumors
Armored CAR-T cells outperform standard therapy in preclinical studies of glioblastoma and ovarian cancer
Mar. 4, 2026
Late Model Annabel Schofield Dies After Cancer Battle
Schofield revealed she wasn't 'out of the woods' with her cancer fight in final social media post.
Mar. 4, 2026
Komodo Health and ZERO Prostate Cancer Announce Partnership
The collaboration aims to improve prostate cancer screening and early detection.
Mar. 4, 2026
QT Imaging Names Renowned Breast Cancer Researcher as Medical Advisor
Dr. Mary Yamashita joins the team to provide expertise on breast cancer imaging technology.
Mar. 4, 2026
Dallas Star Annabel Schofield Dies at 62 After Cancer Battle
The Welsh actress and model publicly documented her two-year fight against the disease.
Mar. 3, 2026
Full House Star Dave Coulier Overcomes Two Separate Cancers
A Story of Early Detection and Survival
Mar. 3, 2026
Leading Acute Myeloid Leukemia Expert Named Dylan Burke Endowed Chair in Immunotherapy
Dr. Soheil Meshinchi recognized for his work in developing novel treatments for AML
Mar. 3, 2026
Kidney cancer study finds belzutifan plus pembrolizumab post-surgery helps patients at high risk for relapse stay cancer-free longer
Combination therapy shows significant improvement in disease-free survival compared to standard treatment alone
Mar. 3, 2026
Unusual Headaches May Signal Brain Tumor, Doctors Warn
Experts say a headache that is different from your normal headaches and continues to worsen should prompt immediate medical attention.
Mar. 3, 2026
Atara Biotherapeutics Seeks FDA Meeting on Tabelecleucel Approval
Company partners with Pierre Fabre Pharmaceuticals to address FDA's concerns and push for accelerated approval of EBV-related cancer treatment.
Mar. 3, 2026
Bhad Bhabie shares cancer battle update: 'Bad news from my doctor'
The rapper revealed she received distressing news about her ongoing cancer treatment.
Mar. 2, 2026
Microplastics Found in 90% of Prostate Cancer Tumors
Study finds double the concentration of plastic particles in cancerous tissue compared to healthy prostate tissue.
Mar. 2, 2026
UC Santa Cruz study finds link between pregnancy and reduced breast cancer risk
Research suggests early pregnancy can permanently change how breast cells age, preventing accumulation of cells that may contribute to tumor growth.
Mar. 2, 2026
South County Residents Notified of Chromium-6 in Tap Water
Costly treatment projects and potential rate hikes loom as county grapples with cancer-linked chemical
Mar. 2, 2026
Bhad Bhabie Shares 'Bad News' About Cancer Battle
The rapper revealed she received 'bad news' from her doctor about her ongoing cancer treatment.
Mar. 2, 2026
Merck, Pfizer's Drug Combo 'Rewrites the Standard of Care' in Bladder Cancer
The new data shows the combo therapy significantly improved survival and treatment response in a late-stage muscle-invasive bladder cancer study.
Mar. 2, 2026
Innovative Cancer Immunotherapy Targets Tumors Without Weakening Immune System
Researchers explore new approaches to overcome cancer's ability to evade the immune system.
Mar. 1, 2026
CytoDyn Presents Promising Data on Leronlimab for Metastatic Breast Cancer
Novel CCR5 inhibition mechanisms and long-term survival signals highlighted at AACR Immuno-Oncology Conference
Feb. 28, 2026
$2M Grant Boosts UC Davis Pancreatic Cancer Battle
Funding will support research into early detection tools for one of the deadliest forms of cancer.
Feb. 28, 2026
New Immunotherapy Drug Shows Promise for Advanced Prostate Cancer
VIR-5500 shrinks tumors and reduces key cancer biomarker in clinical trial